Safety and pharmacokinetics of inhaled morphine delivered using the AERx System in patients with moderate-to-severe asthma

International Journal of Clinical Pharmacology and Therapeutics

Volumn 42, Issue 8, 2004, Pages 456-462

  Otulana, B ^a   Okikawa, J ^a   Linn, L ^a   Morishige, R ^a   Thipphawong, J ^a  

^a ARADIGM CORPORATION   (United States)

Author keywords

Asthma; Asthmatics; Inhaled morphine; Pharmacokinetics; Pulmonary delivery

Indexed keywords

MORPHINE SULFATE; PLACEBO; SALBUTAMOL; SALMETEROL;

ADULT; AEROSOL; AREA UNDER THE CURVE; ARTICLE; ASTHMA; BRONCHOSPASM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE EXACERBATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG SAFETY; DRUG TOLERABILITY; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HEADACHE; HUMAN; HYPERKALEMIA; LUNG FUNCTION TEST; MALE; OPEN STUDY; SINGLE BLIND PROCEDURE; STATISTICAL SIGNIFICANCE; WHEEZING;

EID: 4444381071     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP42456     Document Type: Article

References (20)

1. American Thoracic Society 1995 Standardization of spirometry. Am J Respir Crit Care Med 152. 1107-1136
2. Centers for Disease Control 2001 Morbidity and Mortality Weekly Report. 50: 682-686
3. Chan HK, Daviskas E, Eberl S, Robinson M, Bautovich G, Young I 1999 Deposition of aqueous acrosol of technetium-99m diethylene triamine penta-acetic acid generated and delivered by a novel system (AERx) in healthy subjects. Eur J Nucl Med 26: 320-327
4. Chandler S 1999 Nebulized opioids to treat dyspnea. Am J Hosp Palliat Care 16: 418-422
5. Cipolla DC, Farr SJ, Gonda I, Herst CV, Lee RY, Lloyd P, McKinley G, Rubsumen R, Schuster J, Zellhoefer C 1998 Design and testing of aerosol delivery system for reproducible clinical performance. J Aerosol Med 11 (Suppl 1); S84-S88
6. Crapo RO, Morris AH, Gardner RM 1981 Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 123. 659-664
7. Doenicke A, Moss J, Lorenz W et al 1995 Intravenous morphine and nalbuphine increase histamine and catecholamine release without accompanying hemodynamic changes. Clin Pharmacol Ther 58: 81-89
8. Farr SJ, McElduff A, Matehr LE, Okikawa J, Ward ME, Gonda I, Licko V, Rubsamen RM 2000 Pulmonary insulin administration using the AERx System: physiological and physiochemical factors influencing insulin effectiveness in healthy fasting subjects. Diabetes Technol Ther 2 185-197
9. Gonda I, Schuster J, Rubsamen R, Lloyd P, Cipolla D, Farr SJ 1998 Inhalation delivery systems will, compliance and disease management capabilities. J Contr Release 53: 269-274
10. Hoskin PJ, Hanks GW, Aherne GW, Chapman D, Littleton P, Fiilshie J 1989 The bioavailability and pharmacokinetics of morphine after intravenous, oral and buccal administration in healthy volunteers. Br J Clin Pharmacol 27: 499-505
11. Lang E, Jedekin R 1998 Acute respiratory depression as a complication of nebulized morphine. Can J Anaesth 45: 60-62
12. Masood AR, Thomas HL 1996 Systemic absorption of nebulized morphine compared with oral morphine in healthy subjects. Br J Clin Pharmacol 41: 230-232
13. McKenzie CA, Hobbs AE, Warrick LE 1997 Pain management in the cancer patient. US Pharmacist 22: 7-16
14. Mestiri M, Lurie, Frossard N, Lockart A, Marsac J, Strauch G, Desanges JF 1991 Effect of inhaled morphine on the bronchial response to isocapneic hyperventilation in patients with allergic asthma. Br J Clin Pharm 41: 621
15. National Institutes of Health, National Heart, Blood and Lung Institute 1997 Component I: Measures of Assessment and Monitoring. Guidelines for the Diagnosis and Management of Asthma, Expert Panel Report II. NIH Publication 97-4051: 15-24
16. Otulana BA, Morishige RJ, Beckman RA, Johansson ET Okikawa JK, Fiore MD, Rubsamen RM 1999 Oral Inhalation System for Delivery of Morphine Produces an I.v.-Like PK Profile. Proceedings of the 9th World Congress on Pain, August 22-27, Vienna, Austria
17. Slatkin N, Rauck R, Koczwara B, Chevlen E, Thipphawong J, Morishige R, Otulana B, Beckman R, Gonda I 2002 Analgesic cfficacy of inhaled morphine delivered with the AERx MPMS for breakthrough cancer pain. J Pain 3 (Suppl 1): 43
18. Stevens RA, Ghazi SM 2000 Routes of opioid analgesic therapy in the management of cancer pain. Cancer Cont 7. 132-141
19. Thipphawong J, Babul N, Morishige R, Otulana B, Findlay H, Reber K, Milward G, Sharif S 2002 Single dose analgesic efficacy of inhaled morphine delivered with the AERx morphine pain management system (MPMS) after orthopedic surgery. Pain 3 (Suppl 1): 50
20. Ward ME, Woodhouse A, Mather LE, Farr SJ, Okikawa JK, Lloyd P, Schuster JA, Rubsamen RM 1997 Morphine pharmacokinetics after pulmonary adiministration from a novel aerosol delivery system. Clin Pharm Ther 62: 596-609